Product Description
Endothelial function was evaluated by peripheral artery tonometry using Endo-PAT 2000 (Itamar Medical) (Sourced from: https://pubmed.ncbi.nlm.nih.gov/23209885/)
Mechanisms of Action: Device
Novel Mechanism: No
Modality: Device
Route of Administration: N/A
FDA Designation: *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: Sloan Kettering Medical Center
Company Location: Eastern America
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Phase 4: Prostate Cancer|Prostatic Diseases
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
NCT01500902 |
NCT01500902 | N/A |
Completed |
Acute Coronary Syndrome |
2015-03-01 |
2019-03-19 |
Treatments |
|
NCT01854190 |
CLINEX 02 | N/A |
Completed |
Hypertension|Sleep Apnea, Obstructive |
2013-01-01 |
2019-03-19 |
Treatments |
|
NCT02475057 |
0102-15-RMC | P4 |
Completed |
Prostatic Diseases|Prostate Cancer |
2018-07-01 |
2019-06-13 |
Primary Completion Date|Study Completion Date|Treatments|Trial Status |